Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Sengupta, S., Eavarone, D. A., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 946 · see citing works

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · see citing works

Fluorescence assay for phospholipid membrane asymmetry

McIntyre, J. C., & Sleight, R. G. (1991) · Biochemistry · doi:10.1021/bi00115a012 · Cited by 485 · see citing works

Liposome-based drug delivery in breast cancer treatment

Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469 · see citing works

Cryo transmission electron microscopy of liposomes and related structures

Almgren, M., Edwards, K., & Karlsson, G. (2000) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00516-1 · Cited by 431 · see citing works

Shape transitions and shape stability of giant phospholipid vesicles in pure water induced by area-to-volume changes

Käs, J. A., & Sackmann, E. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82117-8 · Cited by 389 · see citing works

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy

Tardi, P. G., Johnstone, S. A., Harasym, N. L., Xie, S., Harasym, T. O., Zisman, N., Harvie, P., Bermudes, D. G., & Mayer, L. D. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.06.028 · Cited by 357 · see citing works

The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes

McElhaney, R. N. (1982) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(82)90053-6 · Cited by 351 · see citing works

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., & Janoff, A. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0118 · Cited by 332 · see citing works

Gelation of liposome interior A novel method for drug encapsulation

Lasiç, D. D., Frederik, P. M., Stuart, M. C. A., Barenholz, Y., & McIntosh, T. J. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80947-f · Cited by 261 · see citing works

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient

Li, X., Hirsh, D. J., Cabral-Lilly, D., Zirkel, A., Gruner, S. M., Janoff, A. S., & Perkins, W. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00175-8 · Cited by 259 · see citing works

Optimizing Combination Chemotherapy by Controlling Drug Ratios

Mayer, L. D., & Janoff, A. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.4.8 · Cited by 214 · see citing works

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors

Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 214 · see citing works

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

Cullis, P. R., Hope, M. J., Bally, M. B., Madden, T. D., Mayer, L. D., & Fenske, D. B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(97)00006-3 · Cited by 212 · see citing works

Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.

Lasic, D. D., Čeh, B., Stuart, M. C. A., Guo, L., Frederik, P. M., & Barenholz, Y. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00159-z · Cited by 209 · see citing works

Formation of transition metal–doxorubicin complexes inside liposomes

Abraham, S. A., Edwards, K., Karlsson, G., MacIntosh, S., Mayer, L. D., McKenzie, C., & Bally, M. B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00507-2 · Cited by 168 · see citing works

Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo

Tardi, P. G., Gallagher, R. C., Johnstone, S. A., Harasym, N. L., Webb, M. S., Bally, M. B., & Mayer, L. D. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.014 · Cited by 135 · see citing works

Influence of transbilayer area asymmetry on the morphology of large unilamellar vesicles

Mui, B. L., Döbereiner, H. G., Madden, T. D., & Cullis, P. R. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)79967-2 · Cited by 131 · see citing works

Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.

Boman, N. L., Masin, D., Mayer, L. D., Cullis, P. R., & Bally, M. B. (1994) · PubMed · Cited by 126 · see citing works

Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo

Tardi, P. G., Santos, N. D., Harasym, T. O., Johnstone, S. A., Zisman, N., Tsang, A. W., Bermudes, D. G., & Mayer, L. D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0243 · Cited by 122 · see citing works

The determination of liposome captured volume

Perkins, W. R., Minchey, S. R., Ahl, P. L., & Janoff, A. S. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90066-c · Cited by 86 · see citing works

Increased Preclinical Efficacy of Irinotecan and Floxuridine Coencapsulated Inside Liposomes Is Associated With Tumor Delivery of Synergistic Drug Ratios

Harasym, T. O., Tardi, P. G., Harasym, N. L., Harvie, P., Johnstone, S. A., & Mayer, L. D. (2006) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000006783980937 · Cited by 84 · see citing works

The binding of copper ions to daunomycin and adriamycin

Greenaway, F. T., & Dabrowiak, J. C. (1982) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)80218-4 · Cited by 83 · see citing works

Interaction of metal ions with polynucleotides and related compounds. XIV. Nuclear magnetic resonance studies of the binding of copper(II) to adenine nucleotides

Berger, N. A., & Eichhorn, G. L. (1971) · Biochemistry · doi:10.1021/bi00786a019 · Cited by 74 · see citing works

Characterization of the potentiometric behavior of soluble cytochrome oxidase by magnetic circular dichroism. Evidence in support of heme-heme interaction.

Carithers, R. P., & Palmer, G. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43374-1 · Cited by 71 · see citing works

Complexes of Cu(II) with D -aldonic and D -alduronic acids in aqueous solution

Escandar, G. M., & Sala, L. F. (1992) · Canadian Journal of Chemistry · doi:10.1139/v92-259 · Cited by 67 · see citing works

Speciation studies of adriamycin, quelamycin and their metal complexes

May, P. M., Williams, G. K., & Williams, D. R. (1980) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)84195-x · Cited by 59 · see citing works

Dithionite Quenching Rate Measurement of the Inside−Outside Membrane Bilayer Distribution of 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-Labeled Phospholipids

Angeletti, C., & Nichols, J. L. (1998) · Biochemistry · doi:10.1021/bi9810104 · Cited by 56 · see citing works

Magnetic resonance studies of copper(II) interaction with nucleosides and nucleotides

Chao, Y. H., & Kearns, D. R. (1977) · Journal of the American Chemical Society · doi:10.1021/ja00461a041 · Cited by 51 · see citing works

Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes

Dicko, A., Tardi, P. G., Xie, X., & Mayer, L. D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.004 · Cited by 47 · see citing works

The Gluconate Complexes. I. Copper Gluconate Complexes in Strongly Basic Media1

Pecsok, R. L., & Juvet, R. S. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01606a076 · Cited by 41 · see citing works

Pharmacokinetics of CPX-351 (Cytarabine/Daunorubicin HCl) Liposome injection in the mouse

Bayne, W. F., Mayer, L. D., & Swenson, C. E. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21620 · Cited by 40 · see citing works

Intra and Inter-Molecular Interactions Dictate the Aggregation State of Irinotecan Co-Encapsulated with Floxuridine Inside Liposomes

Dicko, A., Frazier, A. A., Liboiron, B. D., Hinderliter, A. K., Ellena, J. F., Xie, X., Cho, C., Weber, T., Tardi, P. G., Cabral-Lilly, D., et al. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9561-z · Cited by 23 · see citing works

Ratiometric dosing of irinotecan (IRI) and floxuridine (FLOX) in a phase I trial: A new approach for enhancing the activity of combination chemotherapy

Batist, G., Miller, W. H., Mayer, L. D., Janoff, A. S., Swenson, C., Louie, A. C., Chi, K. N., Chia, S., & Gelmon, K. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.2549 · Cited by 5 · see citing works

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334 · see citing works

Imaging and drug delivery using theranostic nanoparticles

Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,249 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Clinical cancer nanomedicine

Wolfram, J., & Mauro Ferrari, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.02.005 · Cited by 438 · see citing works

Analytical characterization of liposomes and other lipid nanoparticles for drug delivery

Fan, Y., Marioli, M., & Zhang, K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113642 · Cited by 400 · see citing works

Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery

Almeida, B., Nag, O. K., Rogers, K. E., & Delehanty, J. B. (2020) · Molecules · doi:10.3390/molecules25235672 · Cited by 299 · see citing works

Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery

Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259 · see citing works

Drug nanocrystallisation within liposomes

Li, T., Cipolla, D. C., Rades, T., & Boyd, B. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.001 · Cited by 155 · see citing works

Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment

Nikolova, M. P., Kumar, E. M., & Chavali, M. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102195 · Cited by 133 · see citing works

Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy

Chu, K. S., Schorzman, A. N., Finniss, M. C., Bowerman, C. J., Peng, L., Luft, J. C., Madden, A. J., Wang, A. Z., Zamboni, W. C., & DeSimone, J. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.038 · Cited by 127 · see citing works

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties

Mayer, L. D., Tardi, P. G., & Louie, A. C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s139450 · Cited by 125 · see citing works

Challenges and opportunities in the advancement of nanomedicines

Wei, A., Mehtala, J. G., & Patri, A. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.007 · Cited by 111 · see citing works

Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds

Pauli, G., Tang, W.-L., & Li, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090465 · Cited by 102 · see citing works

Polymer assembly: Promising carriers as co-delivery systems for cancer therapy

Li, N., Zhao, L., Qi, L., Li, Z., & Luan, Y. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.10.009 · Cited by 96 · see citing works

Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

Blair, H. A. (2018) · Drugs · doi:10.1007/s40265-018-1022-3 · Cited by 96 · see citing works

A thermosensitive liposome prepared with a Cu2+ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy

Tagami, T., May, J. P., Ernsting, M. J., & Li, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.023 · Cited by 90 · see citing works

Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine

Salehi, B., Selamoğlu, Z., Mileski, K. S., Pezzani, R., Redaelli, M., Cho, W. C. S., Kobarfard, F., Rajabi, S., Martorell, M., Kumar, P., et al. (2019) · Biomolecules · doi:10.3390/biom9120773 · Cited by 89 · see citing works

Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells

Kim, H. P., Gerhard, B., Harasym, T. O., Mayer, L. D., & Hogge, D. E. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.04.001 · Cited by 87 · see citing works

Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery

Tang, W.-L., Tang, W.-H., Szeitz, A. J., Kulkarni, J. A., Cullis, P. R., & Li, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.004 · Cited by 86 · see citing works

Improving combination cancer therapy: the CombiPlex ® development platform

Tolcher, A. W., & Mayer, L. D. (2018) · Future Oncology · doi:10.2217/fon-2017-0607 · Cited by 80 · see citing works

Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo

Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 75 · see citing works

Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends

Biscaia-Caleiras, M., Fonseca, N. A., Lourenço, A. S., Moreira, J. N., & Simões, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.021 · Cited by 54 · see citing works

Nanoscale Particulate Systems for Multidrug Delivery: Towards Improved Combination Chemotherapy

Liboiron, B. D., & Mayer, L. D. (2014) · Therapeutic Delivery · doi:10.4155/tde.13.149 · Cited by 50 · see citing works

Advances in treatment formulations for acute myeloid leukemia

Briot, T., Roger, E., Thépot, S., & Lagarce, F. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.040 · Cited by 50 · see citing works

Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications

Dhayalan, M., Wang, W., Riyaz, S. U. M., Dinesh, R. A., Shanmugam, J., Irudayaraj, S. S., Stalin, A., Giri, J. P., Mallik, S., & Hu, R. (2024) · 3 Biotech · doi:10.1007/s13205-023-03901-8 · Cited by 48 · see citing works

Nanomedicine to Overcome Antimicrobial Resistance: Challenges and Prospects

Zou, W., McAdorey, A., Yan, H., & Chen, W. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0022 · Cited by 38 · see citing works

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis

Renga, G., Nunzi, E., Stincardini, C., Pariano, M., Puccetti, M., Pieraccini, G., Serio, C. D., Fraziano, M., Poerio, N., Oikonomou, V., et al. (2024) · Blood · doi:10.1182/blood.2023021380 · Cited by 38 · see citing works

Lipid-drug conjugates: a potential nanocarrier system for oral drug delivery applications

Banerjee, S., & Kundu, A. B. (2018) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-018-0209-1 · Cited by 38 · see citing works

Early Development Challenges for Drug Products Containing Nanomaterials

Grossman, J. H., Crist, R. M., & Clogston, J. D. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9980-4 · Cited by 37 · see citing works

What Drives Innovation: The Canadian Touch on Liposomal Therapeutics

Leung, A. W. Y., Amador, C., Wang, L., Mody, U. V., & Bally, M. B. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030124 · Cited by 35 · see citing works

Pharmacokinetics, drug metabolism, and tissue distribution of CPX-351 in animals

Wang, Q., Tardi, P. G., Sadowski, N., Xie, S., Heller, D., & Mayer, L. D. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102275 · Cited by 32 · see citing works

Unique flower-like Cur-metal complexes loaded liposomes for primary and metastatic breast cancer therapy

Zhou, S., Li, J., Yu, J., Wang, Y., Lin, G., Lin, G., He, Z., & Wang, Y. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111835 · Cited by 33 · see citing works

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma

Ntafoulis, I., Koolen, S. L. W., Leenstra, S., & Lamfers, M. L. M. (2022) · Cancers · doi:10.3390/cancers14153705 · Cited by 31 · see citing works

Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy

Pourmadadi, M., Ghaemi, A., Shamsabadipour, A., Rajabzadeh‐Khosroshahi, M., Shaghaghi, M., Rahdar, A., & Pandey, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115547 · Cited by 28 · see citing works

Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity

Yang, Z., Liu, H., Li, S., Xu, Z., Li, W., Liu, Y., Lv, Q., Liu, H., He, Z., & Wang, Y. (2025) · Science Advances · doi:10.1126/sciadv.adw0797 · Cited by 27 · see citing works

Modification of sodium aescinate into a safer, more stable and effective water-soluble drug by liposome-encapsulation: an in vitro and in vivo study

Huang, S., Wang, X., Liu, M., Lin, Z., Gu, W., Zhao, H., Zhang, Y., Ding, B., Liu, J., Wu, X., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058114 · Cited by 25 · see citing works

Remote loading in liposome: a review of current strategies and recent developments

Nambiar, N. R., Gaur, S., Ramachandran, G., Pandey, R. S., Sabitha, M., Nath, L. R., Dutta, T., & Sudheesh, M. S. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2315449 · Cited by 24 · see citing works

Revisiting the outstanding questions in cancer nanomedicine with a future outlook

Sudheesh, M. S., Pavithran, K., & Sabitha, M. (2021) · Nanoscale Advances · doi:10.1039/d1na00810b · Cited by 24 · see citing works

CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?

Brunetti, C., Anelli, L., Zagaria, A., Specchia, G., & Albano, F. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1369400 · Cited by 23 · see citing works

Beyond Traditional Sunscreens: A Review of Liposomal-Based Systems for Photoprotection

Miranda, J. A., da Cruz, Y. F., Girão, Í. C., de Souza, F. J. J., de Oliveira, W. N., Alencar, É. D. N., Amaral-Machado, L., & do Egito, E. S. T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050661 · Cited by 23 · see citing works

Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy

Wang, Z., Li, W., Jiang, Y., Tran, T. B., Chung, J., Kim, M., Scott, A. J., & Lu, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122477 · Cited by 21 · see citing works

Improved antitumor activity and tolerability of cabazitaxel derived remote-loading liposomes

Yang, Z., Chi, D., Wang, Q., Guo, X., Lv, Q., & Wang, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119814 · Cited by 19 · see citing works

A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia

Gergis, U. S., Roboz, G. J., Shore, T. B., Ritchie, E. K., Mayer, S. A., Wissa, U., McKenna, M., Christos, P. J., Pearse, R. N., Mark, T. M., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.04.013 · Cited by 18 · see citing works

Effects of cholesterol concentration on the interaction of cytarabine with lipid membranes: a molecular dynamics simulation study

Karami, L., & Jalili, S. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.941936 · Cited by 18 · see citing works

Current update of a thermosensitive liposomes composed of DPPC and Brij78

Ho, L., Bokharaei, M., & Li, S. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2017.1419361 · Cited by 18 · see citing works

Revisiting the in-vitro and in-vivo considerations for in-silico modelling of complex injectable drug products

Dabke, A., Ghosh, S., Dabke, P., Sawant, K. K., & Khopade, A. J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.029 · Cited by 17 · see citing works

HDACIs and TKIs combinations and their liposomal delivery for cancer treatment

Schelker, C., Nowak-Sliwinska, P. M., & Borchard, G. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.006 · Cited by 15 · see citing works

The effects of intermolecular interactions on the stability and in vitro drug release of daunorubicin/cytarabine co-loaded liposome

Liu, B., Zhang, J., Gou, J., Zhang, Y. X., He, H., Yin, T., Zheng, Z., & Tang, X. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112673 · Cited by 15 · see citing works

Excipient-related impurities in liposome drug products

Wang, C., Gamage, P. L., Jiang, W., & Mudalige, T. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124164 · Cited by 14 · see citing works

Liposomes as Drug Carriers: Classification, Preparation Methods, and Medicinal Use

Бурдаев, Н. И., Николаева, Л. Л., Kosenko, V. V., Шпрах, З. С., & Bunyatyan, N. D. (2023) · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · doi:10.30895/1991-2919-2023-508 · Cited by 13 · see citing works

Understanding the molecular insights of marketed liposomal drugs using molecular dynamics simulations of reduced scale coarse-grained models

Wang, R., Zang, J., Zhong, H., Zhang, Y., & Ouyang, D. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00014-5 · Cited by 13 · see citing works

Experimental Methods to Study the Mechanisms of Interaction of Lipid Membranes with Low-Molecular-Weight Drugs

Le‐Deygen, I. M., Скуредина, А. А., & Kudryashova, E. V. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020040123 · Cited by 12 · see citing works

Liposome‐Enabled Nanomaterials for Muscle Regeneration

Wu, S., & Lu, J. (2025) · Small Methods · doi:10.1002/smtd.202402154 · Cited by 11 · see citing works

Research on the preparation process of the cytarabine/daunorubicin dual-encapsulation liposome and its physicochemical properties and performances in vitro/vivo

Liu, B., Zhang, J., Liu, Z., Wang, P., Zhang, Y. X., He, H., Yin, T., Gou, J., & Tang, X. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123500 · Cited by 10 · see citing works

Contrastive Studies of Cytarabine/Daunorubicin Dual-Loaded Liposomes Prepared by pH Gradient and Cu2+ Gradient Method

Zhang, J., Zhou, L., Zhang, Y. X., He, H., Yin, T., Gou, J., Wang, Y., & Tang, X. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01867-x · Cited by 10 · see citing works

Molecular design and therapeutic applications of polymeric nanoparticles for drug delivery: A comprehensive review

Ahmed, S., Mujahid, M. H., Kour, M., Fatima, S., Ahamad, S., Mishra, S. K., Bhat, A. R., Abu‐Rayyan, A., & Tebeje, B. A. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103459 · Cited by 12 · see citing works

SREKA-targeted liposomes for highly metastatic breast cancer therapy

Vári, B., Dókus, L. E., Borbély, A., Gaál, A., Vári-Mező, D., Ranđelović, I., Tisza, A., Varga, Z., Szoboszlai, N., Mező, G., et al. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2174210 · Cited by 9 · see citing works

Physiological relevance of in-vitro cell-nanoparticle interaction studies as a predictive tool in cancer nanomedicine research

Boinapalli, Y., Pandey, R. S., Chauhan, A. S., & Sudheesh, M. S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122579 · Cited by 7 · see citing works

Interaction of neutral and protonated Tamoxifen with the DPPC lipid bilayer using molecular dynamics simulation

Karami, L. (2023) · Steroids · doi:10.1016/j.steroids.2023.109225 · Cited by 7 · see citing works

Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cells

Di, Y., Wasan, E. K., Cawthray, J. F., & Wasan, K. M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1513026 · Cited by 7 · see citing works

Anti-CD33 antibody enhances liposomal co-delivery of cytarabine and daunorubicin for targeted combination chemotherapy

Li, J., Lu, J., Huang, X., Ding, Y., Zhou, J., Chen, R., Jiang, Z., Fan, X., Yang, Y., Liao, C., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113899 · Cited by 6 · see citing works

In Vivo Assessment of Thermosensitive Liposomes for the Treatment of Port Wine Stains by Antifibrinolytic Site-Specific Pharmaco-Laser Therapy

Li, M., van Raath, M. I., Khakpour, S., Seçilir, A., Sliggers, B. C., Huang, X., Ding, B., Storm, G., van der Hulst, R. R. W. J., de Kroon, A. I. P. M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060591 · Cited by 5 · see citing works

Exploration of the cardinal formulation parameters influencing the encapsulation and physicochemical properties of co-loaded anticancer dual drug nanoliposomes

Ghosh, S., Mishra, P., Banerjee, S., Maiti, K., Khopade, A. J., Misra, A. R., Sawant, K. K., & Bhowmick, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103295 · Cited by 4 · see citing works

Pharmacokinetics and Tissue Distribution of Vinorelbine Bitartrate after Intraveous Administration of Liposomal and Injectable Formulations

Zhang, F., Lin, G., Shao, W., Yu, Y., & Zang, L. (2012) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2012.744691 · Cited by 4 · see citing works

Implementation of design of experiments in liposome manufacturing: ethanol injection and extrusion as a case study

Biscaia-Caleiras, M., Fiteiro, J., Lopes, D., Fidalgo, T., Lourenço, A. S., Moreira, J. N., & Simões, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107236 · Cited by 3 · see citing works

Nanomedicine meets transplantation: Unlocking precision therapeutics for organ rejection

Quan, Y., Ding, M., Hu, X., Xu, G., Cui, N., He, F., Wang, W., Zhou, W., Gao, T., Xie, M., et al. (2025) · EngMedicine · doi:10.1016/j.engmed.2025.100114 · Cited by 3 · see citing works

Evaluation of size-based distribution of components in VYXEOS® liposomal formulation using asymmetric flow field-flow fractionation

Siriwardane, D. A., Shakiba, S., Jiang, W., & Mudalige, T. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465488 · Cited by 3 · see citing works

Nanoscale Delivery Systems for Combination Chemotherapy

Liboiron, B. D., Tardi, P. G., Harasym, T. O., & Mayer, L. D. (2011) · doi:10.1002/9783527634057.ch31 · Cited by 3 · see citing works

Lipid nanoparticles for bone marrow-targeted RNA therapeutics

Casimiro, L. D. M., Escudero, R., Plessis, M. D., Schiffelers, R. M., & Heidenreich, O. T. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04423-0 · Cited by 2 · see citing works

Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies

Zhu, C., Liu, Y., Ji, X., Si, Y., Tao, X., Zhang, X., & Yin, L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091220 · Cited by 2 · see citing works

Contemporary industrial practice for manufacturing of nanomedicines

Tinkov, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-51254-1.00015-4 · Cited by 2 · see citing works

Development of Lipid-Drug Conjugate Nanoparticles for Hydrophilic and Lipophilic Drug: A Comparative Ex vivo Gut and Caco-2 Cell Permeability Study

Kumbhar, P., Manjappa, A. S., Shete, A. D., & Disouza, J. (2020) · Current Nanoscience · doi:10.2174/1573413716666200319130830 · Cited by 2 · see citing works

WITHDRAWN: Polymer assembly: Promising carriers as co-delivery systems for cancer therapy

Li, N., Zhao, L., Qi, L., Li, Z., & Luan, Y. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.11.002 · Cited by 2 · see citing works

Advancements in nanophyto formulations

Jose, A., Sreekanth, K., & Radhakrishnan, E. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88450-1.00010-7 · Cited by 2 · see citing works

Versatile Fixed-Ratio Drug Combination Delivery Using Hydrophobic Prodrug Nanoparticles

Liboiron, B. D., Tardi, P. G., & Mayer, L. D. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_6 · Cited by 1 · see citing works

Development of Phosphatidylethanolamine Liposomes That Efficiently Retain Encapsulated Vinorelbine Bitartrate

Zhang, F., Shao, W., & Lin, G. (2012) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2011.567939

Core-Shell Nanoparticles for Biomedical Applications

Elsabahy, M., & Wooley, K. L. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0013

In Vivo Monitoring of Liposomal Encapsulated siRNA Delivery

Kenny, G. D. (2010) · Spiral (Imperial College London) · doi:10.25560/6208

Commercial and Regulatory Development Considerations for Nanomedicines

Hillery, A., & Park, K. (2016) · CRC Press eBooks · doi:10.1201/9781315382579-22

Recognizing the potential for copper-related toxicities from liposomal daunorubicin--cytarabine

Newman, M. J. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155221994322

Immunotherapy and Vaccines

(2015) · doi:10.1201/b19860-19

In Vitro Investigation of Vitamin K3 and Doxorubicin Administration Regimens for Anticancer Activity in Free and Liposomal FormsPreprint

Akkad, S., Dalgıç, A. D., Ozen, C., & Keskin, D. S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4755895

Commercialized nanomedicines until to date

Kainthan, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22257-3.00015-5

Development of Nanotheronostics

Shaikh, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7292-6_21

Liposomes: Design, Development, Structure, Composition, Types and Related Techniques

Chu, C., Hua, C., & Geng, S. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674220-00019

A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications

Prajapati, S., Kumar, A., & Singh, R. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae83f7

Surface modified metal nanoparticles in colon cancer

Tomar, P., Yadav, S., & Chettupalli, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40443-6.00024-6

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties

Mayer, L. D., Tardi, P. G., & Louie, A. C. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2 · see citing works

Pharmacokinetics of CPX-351 (Cytarabine/Daunorubicin HCl) Liposome injection in the mouse

Bayne, W. F., Mayer, L. D., & Swenson, C. E. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21620 · Cited by 40 · see citing works

Research on the preparation process of the cytarabine/daunorubicin dual-encapsulation liposome and its physicochemical properties and performances in vitro/vivo

Liu, B., Zhang, J., Liu, Z., Wang, P., Zhang, Y. X., He, H., Yin, T., Gou, J., & Tang, X. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123500 · Cited by 10 · see citing works

Synergistic Cytarabine:Daunorubicin Ratios Delivered by CPX-351 to Human Leukemia Xenografts Is Associated with Liposome-Mediated Bone Marrow Drug Accumulation, Intracellular Delivery of Encapsulated Agents to Leukemia Cells, and Increased Efficacy.

Mayer, L. D., Lim, W.-S., Santos, N. D., Xie, S., Hopkins, A., Huang, R. Y., Wilkins, L., Kelly, S. C., Bermudes, D. G., Harasym, T. O., et al. (2008) · Blood · doi:10.1182/blood.v112.11.942.942 · Cited by 3 · see citing works

Abstract 5464: Determination of total and encapsulated drug pharmacokinetics for CPX-351, a nanoscale liposomal fixed molar ratio of cytarabine-daunorubicin (Cyt:Daun)

Ciofani, T., Harasym, T. O., Juan, M. C. Y., Mayer, L. D., Cabral-Lilly, D., & Xie, S. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-5464 · Cited by 5 · see citing works